Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine + eCBT for Treatment Resistant PTSD
NCT04771767Phase 2Unknown
- Sponsor
- Queen's University
- Start
- Aug 2021
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in post-traumatic stress disorder (PTSD), sponsored by Queen's University. Status: unknown.
02
Drugs
ketamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT04771767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04771767.